Argenica Therapeutics Health Care
Biotech Healthcare

$0.375 0.005 (1.35%)

High $0.38	Low $0.38	Trades 2	Turnover $1,293	Volume 3,448
30 June 2023 at 10:43am

Market Cap (5-Aug) $19,268,508 (1,586th)	Close (30-Jun) $0.375 0 (0%)	Volume (30-Jun) 3,448	Shortsold (3-Jul) 15,198 (0.01%) (627th)
52w High $0.77	52w Low $0.087	P/E -	EPS -0.08

Short Interest

ASIC data, 3 Jul 2026

% Shorted

0.01% 0.01

vs 0.00% prior report

Most Shorted Rank

627th

of 716 shorted ASX stocks

Peak Short

0.01%

Jul 2026

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	AGN AGN Ann: Investor Presentation - Updated
	1 (current) 2 3
	AGN AGN Ann: Change of Director's Interest Notice x2
	AGN AGN Ann: Investor Presentation
	AGN AGN Ann: Notification regarding unquoted securities - AGN
	AGN AGN Ann: Cleansing Notice
	AGN AGN Ann: Application for quotation of securities - AGN
	AGN AGN Ann: Proposed issue of securities - AGN
	AGN AGN Ann: Proposed issue of securities - AGN
	AGN AGN Ann: Argenica Successfully Completes $5.5m Placement
	AGN AGN Ann: Trading Halt
	AGN AGN Ann: Successful Completion of Final Pre-Clinical PK Study
	AGN AGN Ann: GLP Safety Studies Successfully Completed
	AGN AGN Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	AGN AGN Ann: Maximum Tolerated Dose Successfully Established in Studies
	AGN AGN Ann: Initial Director's Interest Notice
	AGN AGN Ann: Argenica Appoints CEO Dr Liz Dallimore Managing Director
	AGN AGN Ann: Positive Preclincal Data on Efficacy in New Indication
	AGN AGN Ann: Peer Reviewed Paper Published on Preclinical Study
	AGN AGN Ann: Investor Presentation
	AGN AGN Ann: Change of Director's Interest Notice
	AGN AGN Ann: Successful Completion of Final GLP Genotoxicity Studies
	AGN AGN Ann: Half Yearly Report and Accounts
	AGN AGN Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	AGN AGN Ann: Preliminary Pre-Clinical Tox Studies Successfully Completed
	AGN AGN Ann: Argenica Appoints Head of Clinical Development
	AGN AGN Ann: Notification regarding unquoted securities - AGN
	AGN AGN Ann: Application for quotation of securities - AGN
	AGN AGN Ann: Application for quotation of securities - AGN
	AGN AGN Ann: Release of Restricted Securities from Escrow
	AGN AGN Ann: Argenica to be Granted Patent Protection in the US
	AGN AGN Ann: Results of Annual General Meeting
	AGN AGN Ann: AGM Presentation
	AGN AGN Ann: Positive Preclinical Data for ARG-007 Neuroprotection in HIE
	AGN AGN Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	AGN AGN Ann: Investor Presentation
	AGN AGN Ann: Phase 1 Clinical Trial Overview & Roadmap
	AGN AGN Ann: Notice of Annual General Meeting/Proxy Form
	AGN AGN Ann: Application for quotation of securities - AGN
	AGN AGN Ann: Release of Restricted Securities from Escrow
	AGN AGN Ann: Argenica Partners With Linear For Phase 1 Clinical Trial
	AGN AGN Ann: Date of AGM & Closing Date for Director Nominations
	AGN AGN Ann: Argenica Achieves Manufacturing Milestones
	AGN AGN Ann: Appendix 4G & Corporate Governance Statement
	AGN AGN Ann: Appendix 4E & Annual Report 30 June 2021
	AGN AGN Ann: Appendix 3G
	AGN AGN Ann: Proposed issue of securities - AGN
	AGN AGN Ann: Issue of Options
	AGN AGN Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	AGN AGN Ann: Grant Secured to Advance Pre-Clinical Studies Of ARG-007
	AGN AGN Ann: Study Additional Information

End of Day Prices

Date	Close	Volume	Change
05-Aug	$0.15	29,264	-0.01 (3.23%)
04-Aug	$0.16	7,179	0.00 (0.00%)
03-Aug	$0.16	48,715	0.00 (0.00%)
31-Jul	$0.16	26,176	+0.01 (3.33%)
30-Jul	$0.15	567,539	0.00 (0.00%)
29-Jul	$0.15	881,067	-0.02 (11.76%)
28-Jul	$0.17	42,509	+0.01 (6.25%)
27-Jul	$0.16	188,938	+0.01 (3.23%)
24-Jul	$0.16	100,832	+0.01 (3.33%)
23-Jul	$0.15	8,740	-0.01 (3.23%)
22-Jul	$0.16	256,452	+0.01 (6.90%)
21-Jul	$0.15	171,982	-0.02 (9.38%)
20-Jul	$0.16	470,812	0.00 (0.00%)
17-Jul	$0.16	428,619	-0.13 (44.83%)
18-Sep	$0.29	381,039	-0.03 (9.38%)
5 up, 6 down, and 4 flat days

Argenica Therapeutics Health Care
Biotech Healthcare

Short Interest

Followers

Prices

Announcements

End of Day Prices

AGN Argenica Therapeutics Health Care Biotech Healthcare

Short Interest

Followers

Prices

Announcements

End of Day Prices

Argenica Therapeutics Health Care
Biotech Healthcare